[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
June 20, 2001

Warfarin = Aspirin for Stroke

Author Affiliations

Not Available

Not Available

JAMA. 2001;285(23):2966. doi:10.1001/jama.285.23.2966

Because 60% of patients who have an ischemic stroke have a recurrence within 2 years, physicians generally prescribe an anticoagulant, the most common being aspirin or warfarin. A large head-to-head study, reported at the May meeting of the American Academy of Neurology (AAN), shows that the two drugs perform equally well in reducing recurrence.

However, because warfarin is more difficult to prescribe and more expensive, the findings will result in the gradual abandonment of warfarin for these patients, said Vladimir Hachinski, MD, of the University of Western Ontario, London.